Angiotensin II Protects Primary Rat Hepatocytes against Bile Salt-Induced Apoptosis

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Karimian, Golnar ^a   Buist Homan, Manon ^a   Mikus, Bojana ^a   Henning, Robert H ^a   Faber, Klaas Nico ^a   Moshage, Han ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANGIOTENSIN II; BILE SALT; CACTINOMYCIN; CYTOKINE; GLYCOCHENODEOXYCHOLIC ACID; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; MENADIONE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE C; TAUROLITHOCHOLIC ACID; TAUROLITHOCHOLIC ACID 3 SULFATE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVATION; ENZYME INHIBITION; LIVER CELL; LIVER PROTECTION; MALE; NONHUMAN; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT;

ANGIOTENSIN II; ANIMALS; APOPTOSIS; CASPASE 3; CELL SHAPE; CELLS, CULTURED; DACTINOMYCIN; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVATION; GLYCOCHENODEOXYCHOLIC ACID; HEPATOCYTES; MALE; MAP KINASE SIGNALING SYSTEM; OXIDATIVE STRESS; PHOSPHATIDYLINOSITOL 3-KINASES; PRIMARY CELL CULTURE; PROTEIN KINASE C; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; RECEPTOR, ANGIOTENSIN, TYPE 1; TAUROLITHOCHOLIC ACID; TUMOR NECROSIS FACTOR-ALPHA; VITAMIN K 3;

RATTUS;

EID: 84871594528     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0052647     Document Type: Article

References (65)

1. Bader M, Ganten D, (2008) Update on tissue renin-angiotensin systems. Journal of Molecular Medicine (Berlin, Germany) 86: 615-621.
2. Paul M, Poyan Mehr A, Kreutz R, (2006) Physiology of local renin-angiotensin systems. Physiological Reviews 86: 747-803.
3. Paizis G, Cooper M, Schembri J, Tikellis C, Burrell L, et al. (2002) Up-regulation of components of the renin-angiotensin system in the bile duct-ligated rat liver. Gastroenterology 123: 1667-76.
4. Bataller R, Sancho-Bru P, Ginès P, Lora J, Al-Garawi A, et al. (2003) Activated human hepatic stellate cells express the renin-angiotensin system and synthesize angiotensin II. Gastroenterology 125: 117-25.
5. Warner FJ, Lubel JS, McCaughan GW, Angus PW, (2007) Liver fibrosis: A balance of ACEs? Clinical Science (London, England: 1979) 113: 109-118.
6. Leung PS, (2004) The peptide hormone angiotensin II: Its new functions in tissues and organs. Current Protein & Peptide Science 5: 267-273.
7. Paizis G, Tikellis C, Cooper M, Schembri J, Lew R, et al. (2005) Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2. Gut 54: 1790-6.
8. Ikura Y, Ohsawa M, Shirai N, Sugama Y, Fukushima H, et al. (2005) Expression of angiotensin II type 1 receptor in human cirrhotic livers: Its relation to fibrosis and portal hypertension. Hepatology Research: The Official Journal of the Japan Society of Hepatology 32: 107-116.
9. Asbert M, Jimenez W, Gaya J, Gines P, Arroyo V, et al. (1992) Assessment of the renin-angiotensin system in cirrhotic patients. comparison between plasma renin activity and direct measurement of immunoreactive renin. Journal of Hepatology 15: 179-183.
10. Bataller R, Ginès P, Nicolás J, Görbig M, Garcia-Ramallo E, et al. (2000) Angiotensin II induces contraction and proliferation of human hepatic stellate cells. Gastroenterology 118: 1149-56.
11. Bataller R, Gäbele E, Parsons C, Morris T, Yang L, et al. (2005) Systemic infusion of angiotensin II exacerbates liver fibrosis in bile duct-ligated rats. Hepatology 41: 1046-55.
12. El-Demerdash E, Salam O, El-Batran S, Abdallah H, Shaffie N, (2008) Inhibition of the renin-angiotensin system attenuates the development of liver fibrosis and oxidative stress in rats. Clin Exp Pharmacol Physiol 35: 159-67.
13. Hirose A, Ono M, Saibara T, Nozaki Y, Masuda K, et al. (2007) Angiotensin II type 1 receptor blocker inhibits fibrosis in rat nonalcoholic steatohepatitis. Hepatology 45: 1375-81.
14. Abu Dayyeh BK, Yang M, Dienstag JL, Chung RT, (2011) The effects of angiotensin blocking agents on the progression of liver fibrosis in the HALT-C trial cohort. Digestive Diseases and Sciences 56: 564-568.
15. Nygaard B, Strandgaard S, (1996) Marked hepatotoxicity associated with losartan treatment. Blood Pressure 5: 190-191.
16. Bosch X, (1997) Losartan-induced hepatotoxicity. JAMA: The Journal of the American Medical Association 278: 1572.
17. Andrade RJ, Lucena MI, Santalla F, (1998) Hepatic injury associated with losartan. The Annals of Pharmacotherapy 32: 1371.
18. Tabak F, Mert A, Ozaras R, Biyikli M, Ozturk R, et al. (2002) Losartan-induced hepatic injury. Journal of Clinical Gastroenterology 34: 585-586.
19. Basile G, Villari D, Gangemi S, Ferrara T, Accetta MG, et al. (2003) Candesartan cilexetil-induced severe hepatotoxicity. Journal of Clinical Gastroenterology 36: 273-275.
20. Vallejo I, Garcia Morillo S, Pamies E, (2000) Acute hepatitis induced by candesartan. Medicina Clinica 115: 719.
21. Hariraj R, Stoner E, Jader S, Preston DM, (2000) Drug points: Prolonged cholestasis associated with irbesartan. BMJ (Clinical Research Ed.) 321: 547.
22. Andrade RJ, Lucena MI, Fernandez MC, Vega JL, Garcia-Cortes M, et al. (2002) Cholestatic hepatitis related to use of irbesartan: A case report and a literature review of angiotensin II antagonist-associated hepatotoxicity. European Journal of Gastroenterology & Hepatology 14: 887-890.
23. Rene JM, Buenestado J, Sese E, Minana JM, (2001) Acute hepatitis induced by valsartan. Medicina Clinica 117: 637-638.
24. Kiykim A, Altintas E, Sezgin O, Sezer K, Tiftik N, et al. (2003) Valsartan-induced hepatotoxicity in a HBs-ag-positive patient. The American Journal of Gastroenterology 98: 507.
25. Guo JJ, Wigle PR, Lammers K, Vu O, (2005) Comparison of potentially hepatotoxic drugs among major US drug compendia. Research in Social & Administrative Pharmacy: RSAP 1: 460-479.
26. Moshage H, Casini A, Lieber C, (1990) Acetaldehyde selectively stimulates collagen production in cultured rat liver fat-storing cells but not in hepatocytes. Hepatology 12: 511-8.
27. Schoemaker M, Conde de la Rosa L, Buist-Homan M, Vrenken T, Havinga R, et al. (2004) Tauroursodeoxycholic acid protects rat hepatocytes from bile acid-induced apoptosis via activation of survival pathways. Hepatology 39: 1563-73.
28. Woudenberg-Vrenken TE, Buist-Homan M, Conde de la Rosa L, Faber KN, Moshage H, (2010) Anti-oxidants do not prevent bile acid-induced cell death in rat hepatocytes. Liver International: Official Journal of the International Association for the Study of the Liver 30: 1511-1521.
29. Conde de la Rosa L, Schoemaker M, Vrenken T, Buist-Homan M, Havinga R, et al. (2006) Superoxide anions and hydrogen peroxide induce hepatocyte death by different mechanisms: Involvement of JNK and ERK MAP kinases. J Hepatol 44: 918-29.
30. Bernstein H, Payne CM, Bernstein C, Schneider J, Beard SE, et al. (1999) Activation of the promoters of genes associated with DNA damage, oxidative stress, ER stress and protein malfolding by the bile salt, deoxycholate. Toxicology Letters 108: 37-46.
31. Tsuchiya S, Tsuji M, Morio Y, Oguchi K, (2006) Involvement of endoplasmic reticulum in glycochenodeoxycholic acid-induced apoptosis in rat hepatocytes. Toxicol Lett 166: 140-9.
32. Ji C, Kaplowitz N, (2006) ER stress: Can the liver cope? Journal of Hepatology 45: 321-333.
33. Tamaki N, Hatano E, Taura K, Tada M, Kodama Y, et al. (2008) CHOP deficiency attenuates cholestasis-induced liver fibrosis by reduction of hepatocyte injury. Am J Physiol Gastrointest Liver Physiol 294: G498-505.
34. Morris BJ, Iwamoto HS, Reid IA, (1979) Localization of angiotensinogen in rat liver by immunocytochemistry. Endocrinology 105: 796-800.
35. Brasier A, Jamaluddin M, Han Y, Patterson C, Runge M, (2000) Angiotensin II induces gene transcription through cell-type-dependent effects on the nuclear factor-kappaB (NF-kappaB) transcription factor. Mol Cell Biochem 212: 155-69.
36. Weng Y, Shukla S, (2002) Angiotensin II activation of focal adhesion kinase and pp60c-src in relation to mitogen-activated protein kinases in hepatocytes. Biochim Biophys Acta 1589: 285-97.
37. Fang Y, Han SI, Mitchell C, Gupta S, Studer E, Grant S, et al. (2004) Bile acids induce mitochondrial ROS, which promote activation of receptor tyrosine kinases and signaling pathways in rat hepatocytes. Hepatology 40: 961-971.
38. Perez MJ, Gonzalez-Sanchez E, Gonzalez-Loyola A, Gonzalez-Buitrago JM, Marin JJG, (2011) Mitochondrial genome depletion dysregulates bile acid- and paracetamol-induced expression of the transporters Mdr1, Mrp1 and Mrp4 in liver cells. British Journal of Pharmacology 162: 1686-1699.
39. Saelens X, Festjens N, Vande Walle L, van Gurp M, van Loo G, et al. (2004) Toxic proteins released from mitochondria in cell death. Oncogene 23: 2861-2874.
40. Schoemaker M, Ros J, Homan M, Trautwein C, Liston P, et al. (2002) Cytokine regulation of pro- and anti-apoptotic genes in rat hepatocytes: NF-kappaB-regulated inhibitor of apoptosis protein 2 (cIAP2) prevents apoptosis. J Hepatol 36: 742-50.
41. Schoemaker M, Gommans W, Conde de la Rosa L, Homan M, Klok P, et al. (2003) Resistance of rat hepatocytes against bile acid-induced apoptosis in cholestatic liver injury is due to nuclear factor-kappa B activation. J Hepatol 39: 153-61.
42. Rust C, Wild N, Bernt C, Vennegeerts T, Wimmer R, et al. (2009) Bile acid-induced apoptosis in hepatocytes is caspase-6-dependent. The Journal of Biological Chemistry 284: 2908-2916.
43. Weng Y, Aroor A, Shukla S, (2008) Ethanol inhibition of angiotensin II-stimulated Tyr705 and Ser727 STAT3 phosphorylation in cultured rat hepatocytes: Relevance to activation of p42/44 mitogen-activated protein kinase. Alcohol 42: 397-406.
44. Weng Y, Shukla S, (2003) Effects of chronic ethanol treatment on the angiotensin II-mediated p42/p44 mitogen-activated protein kinase and phosphorylase a activation in rat hepatocytes. Alcohol 29: 83-90.
45. Higuchi S, Ohtsu H, Suzuki H, Shirai H, Frank G, et al. (2007) Angiotensin II signal transduction through the AT1 receptor: Novel insights into mechanisms and pathophysiology. Clin Sci (Lond) 112: 417-28.
46. Nakashima H, Frank G, Shirai H, Hinoki A, Higuchi S, et al. (2008) Novel role of protein kinase C-delta tyr 311 phosphorylation in vascular smooth muscle cell hypertrophy by angiotensin II. Hypertension 51: 232-8.
47. Yano N, Suzuki D, Endoh M, Zhao TC, Padbury JF, et al. (2007) A novel phosphoinositide 3-kinase-dependent pathway for angiotensin II/AT-1 receptor-mediated induction of collagen synthesis in MES-13 mesangial cells. The Journal of Biological Chemistry 282: 18819-18830.
48. Beltran AE, Briones AM, Garcia-Redondo AB, Rodriguez C, Miguel M, et al. (2009) p38 MAPK contributes to angiotensin II-induced COX-2 expression in aortic fibroblasts from normotensive and hypertensive rats. Journal of Hypertension 27: 142-154.
49. Yoshiji H, Kuriyama S, Yoshii J, Ikenaka Y, Noguchi R, et al. (2003) Angiotensin-II induces the tissue inhibitor of metalloproteinases-1 through the protein kinase-C signaling pathway in rat liver fibrosis development. Hepatol Res 27: 51-56.
50. Hsieh Y, Jao H, Yang R, Hsu H, Hsu C, (2003) Suppression of protein kinase calpha triggers apoptosis through down-regulation of bcl-xL in a rat hepatic epithelial cell line. Shock 19: 582-7.
51. Jao H, Yang R, Hsu H, Hsu C, (2001) The decrease of PKCalpha is associated with hepatic apoptosis at early and late phases of polymicrobial sepsis. Shock 15: 130-4.
52. Oyadomari S, Mori M, (2004) Roles of CHOP/GADD153 in endoplasmic reticulum stress. Cell Death Differ 11: 381-9.
53. Matsumoto M, Minami M, Takeda K, Sakao Y, Akira S, (1996) Ectopic expression of CHOP (GADD153) induces apoptosis in M1 myeloblastic leukemia cells. FEBS Letters 395: 143-147.
54. Barone MV, Crozat A, Tabaee A, Philipson L, Ron D, (1994) CHOP (GADD153) and its oncogenic variant, TLS-CHOP, have opposing effects on the induction of G1/S arrest. Genes & Development 8: 453-464.
55. Puthalakath H, O'Reilly LA, Gunn P, Lee L, Kelly PN, et al. (2007) ER stress triggers apoptosis by activating BH3-only protein bim. Cell 129: 1337-1349.
56. Yamaguchi H, Wang HG, (2004) CHOP is involved in endoplasmic reticulum stress-induced apoptosis by enhancing DR5 expression in human carcinoma cells. The Journal of Biological Chemistry 279: 45495-45502.
57. McCullough KD, Martindale JL, Klotz LO, Aw TY, Holbrook NJ, (2001) Gadd153 sensitizes cells to endoplasmic reticulum stress by down-regulating Bcl2 and perturbing the cellular redox state. Molecular and Cellular Biology 21: 1249-1259.
58. Oyadomari S, Koizumi A, Takeda K, Gotoh T, Akira S, et al. (2002) Targeted disruption of the chop gene delays endoplasmic reticulum stress-mediated diabetes. The Journal of Clinical Investigation 109: 525-532.
59. Hu P, Han Z, Couvillon A, Exton J, (2004) Critical role of endogenous Akt/IAPs and MEK1/ERK pathways in counteracting endoplasmic reticulum stress-induced cell death. J Biol Chem 279: 49420-9.
60. Price J, Zaidi AK, Bohensky J, Srinivas V, Shapiro IM, et al. (2010) Akt-1 mediates survival of chondrocytes from endoplasmic reticulum-induced stress. Journal of Cellular Physiology 222: 502-508.
61. Yuan Y, Guo Q, Ye Z, Pingping X, Wang N, et al. (2011) Ischemic postconditioning protects brain from ischemia/reperfusion injury by attenuating endoplasmic reticulum stress-induced apoptosis through PI3K-akt pathway. Brain Research 1367: 85-93.
62. Lee W, Kim D, Boo J, Kim Y, Park I, et al. (2005) ER stress-induced caspase-12 activation is inhibited by PKC in neuronal cells. Apoptosis 10: 407-15.
63. Xie Q, Khaoustov V, Chung C, Sohn J, Krishnan B, et al. (2002) Effect of tauroursodeoxycholic acid on endoplasmic reticulum stress-induced caspase-12 activation. Hepatology 36: 592-601.
64. Moreno M, Gonzalo T, Kok RJ, Sancho-Bru P, van Beuge M, et al. (2010) Reduction of advanced liver fibrosis by short-term targeted delivery of an angiotensin receptor blocker to hepatic stellate cells in rats. Hepatology (Baltimore, Md.) 51: 942-952.
65. Roma MG, Toledo FD, Boaglio AC, Basiglio CL, Crocenzi FA, et al. (2011) Ursodeoxycholic acid in cholestasis: Linking action mechanisms to therapeutic applications. Clinical Science (London, England: 1979) 121: 523-544.